Clinical trial with omics and imaging data to study response to treatment.

Mitochondrial inhibitor atovaquone increases tumor oxygenation and inhibits hypoxic gene expression in patients with non-small cell lung cancer

Buffa, Francesca M.
Formal Analysis
;
2021-01-01

Abstract

Clinical trial with omics and imaging data to study response to treatment.
2021
Skwarski, Michael; Mcgowan, Daniel R.; Belcher, Elizabeth; Di Chiara, Francesco; Stavroulias, Dionisios; Mccole, Mark; Derham, Jennifer L.; Chu, Kwun-Ye; Teoh, Eugene; Chauhan, Jagat; O’Reilly, Dawn; Harris, Benjamin H. L.; Macklin, Philip S.; Bull, Joshua A.; Green, Marcus; Rodriguez-Berriguete, Gonzalo; Prevo, Remko; Folkes, Lisa K.; Campo, Leticia; Ferencz, Petra; Croal, Paula L.; Flight, Helen; Qi, Cathy; Holmes, Jane; O’Connor, James P. B.; Gleeson, Fergus V.; Mckenna, W. Gillies; Harris, Adrian L.; Bulte, Daniel; Buffa, Francesca M.; Macpherson, Ruth E.; Higgins, Geoff S.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11565/4052505
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 17
social impact